Meddex Méz Ízű

Dextromethorphan Hydrobromide, the active ingredient in Meddex Méz Ízű, is an antitussive (NMDA receptor antagonist) presented as an oral formulation for oral use. It is intended for temporary relief of cough associated with minor throat and bronchial irritation, such as that occurring with the common cold, in adults and children when appropriate. GNH USA supplies Meddex Méz Ízű as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Dextromethorphan Hydrobromide acts on the central cough pathway to suppress unwanted coughing. - Minor throat irritation: provides temporary relief of cough caused by irritation of the throat. - Bronchial irritation: reduces cough frequency associated with mild bronchial irritation. - Common cold cough: alleviates cough that accompanies a typical cold infection.

Adverse reactions may occur with dextromethorphan use.

Common Side Effects: - Dizziness: mild sensation of light‑headedness. - Nausea: feeling of stomach upset. - Dry mouth: reduced salivation. - Fatigue: unusual tiredness. - Gastrointestinal discomfort: mild abdominal pain or upset.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Psychiatric effects: hallucinations, confusion, or agitation. - Cardiac arrhythmia: irregular heartbeat in susceptible individuals. - Severe respiratory depression: rare, especially with overdose or concomitant depressants.

Before using Meddex Méz Ízű, consider the following safety measures. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: discuss potential risks with a physician. - Age restrictions: avoid use in children under the recommended age without medical advice. - Concomitant CNS depressants: use caution when combined with alcohol, opioids, or sedatives. - Underlying medical conditions: inform the prescriber of liver disease, heart disease, or psychiatric disorders. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Dextromethorphan may interact with other medicines, altering its effect or safety profile.

Major Interactions (Avoid): - MAO inhibitors: risk of severe serotonin syndrome. - Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may increase dextromethorphan levels.

Moderate Interactions (Monitor Closely):\n- CNS depressants (alcohol, benzodiazepines): may enhance drowsiness. - Antihistamines: could increase sedation. - Certain antipsychotics: may affect metabolism and increase side‑effect risk.